Bluejay Diagnostics, Inc.
BJDX
$1.66
-$0.11-6.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.86M | -1.43M | -1.48M | -2.48M | -2.33M |
| Total Depreciation and Amortization | 51.90K | 37.50K | 53.60K | 53.70K | 54.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.30K | -500.10K | 191.90K | 628.20K | 11.90K |
| Change in Net Operating Assets | 626.40K | 155.90K | -694.90K | -60.10K | -37.70K |
| Cash from Operations | -1.18M | -1.74M | -1.93M | -1.85M | -2.30M |
| Capital Expenditure | -- | -1.10K | -200.00 | -270.00K | -35.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -1.10K | -200.00 | -270.00K | -35.40K |
| Total Debt Issued | -- | 0.00 | 0.00 | 2.00M | -- |
| Total Debt Repaid | -1.00K | 286.40K | -371.60K | -1.91M | -900.00 |
| Issuance of Common Stock | -- | 0.00 | 500.00 | 8.57M | 3.50M |
| Repurchase of Common Stock | -- | -400.00 | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -1.13M | -711.00K |
| Cash from Financing | -1.00K | 286.00K | -371.00K | 7.52M | 2.79M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.19M | -1.45M | -2.30M | 5.40M | 452.70K |